Jazz Pharmaceuticals (JAZZ) Competitors $131.72 +2.06 (+1.59%) Closing price 04:00 PM EasternExtended Trading$131.71 -0.01 (-0.01%) As of 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JAZZ vs. AXSM, RPRX, CORT, PRGO, SUPN, PCRX, NKTR, OMER, ASMB, and CPIXShould you be buying Jazz Pharmaceuticals stock or one of its competitors? The main competitors of Jazz Pharmaceuticals include Axsome Therapeutics (AXSM), Royalty Pharma (RPRX), Corcept Therapeutics (CORT), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Omeros (OMER), Assembly Biosciences (ASMB), and Cumberland Pharmaceuticals (CPIX). These companies are all part of the "medical" sector. Jazz Pharmaceuticals vs. Its Competitors Axsome Therapeutics Royalty Pharma Corcept Therapeutics Perrigo Supernus Pharmaceuticals Pacira BioSciences Nektar Therapeutics Omeros Assembly Biosciences Cumberland Pharmaceuticals Jazz Pharmaceuticals (NASDAQ:JAZZ) and Axsome Therapeutics (NASDAQ:AXSM) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings. Do analysts rate JAZZ or AXSM? Jazz Pharmaceuticals currently has a consensus target price of $178.67, indicating a potential upside of 35.64%. Axsome Therapeutics has a consensus target price of $177.86, indicating a potential upside of 45.78%. Given Axsome Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Axsome Therapeutics is more favorable than Jazz Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jazz Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.88Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 3.07 Do institutionals and insiders believe in JAZZ or AXSM? 89.1% of Jazz Pharmaceuticals shares are held by institutional investors. Comparatively, 81.5% of Axsome Therapeutics shares are held by institutional investors. 4.3% of Jazz Pharmaceuticals shares are held by company insiders. Comparatively, 22.4% of Axsome Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor JAZZ or AXSM? In the previous week, Jazz Pharmaceuticals had 8 more articles in the media than Axsome Therapeutics. MarketBeat recorded 32 mentions for Jazz Pharmaceuticals and 24 mentions for Axsome Therapeutics. Axsome Therapeutics' average media sentiment score of 1.13 beat Jazz Pharmaceuticals' score of 1.08 indicating that Axsome Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jazz Pharmaceuticals 17 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Axsome Therapeutics 17 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, JAZZ or AXSM? Jazz Pharmaceuticals has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Comparatively, Axsome Therapeutics has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Which has higher earnings and valuation, JAZZ or AXSM? Jazz Pharmaceuticals has higher revenue and earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJazz Pharmaceuticals$4.07B1.96$560.12M-$6.73-19.57Axsome Therapeutics$385.69M15.78-$287.22M-$5.07-24.06 Is JAZZ or AXSM more profitable? Jazz Pharmaceuticals has a net margin of -9.91% compared to Axsome Therapeutics' net margin of -49.88%. Jazz Pharmaceuticals' return on equity of 5.02% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Jazz Pharmaceuticals-9.91% 5.02% 1.73% Axsome Therapeutics -49.88%-283.22%-33.06% SummaryJazz Pharmaceuticals and Axsome Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JAZZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAZZ vs. The Competition Export to ExcelMetricJazz PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.75B$3.12B$5.77B$9.77BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-19.5721.1082.3726.60Price / Sales1.96408.88536.82175.38Price / Cash4.2143.5325.7028.92Price / Book2.168.1310.646.56Net Income$560.12M-$53.35M$3.28B$266.04M7 Day Performance5.86%0.45%-0.08%-0.58%1 Month Performance14.02%9.94%10.36%6.24%1 Year Performance20.49%11.73%49.00%22.21% Jazz Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAZZJazz Pharmaceuticals4.699 of 5 stars$131.72+1.6%$178.67+35.6%+11.8%$7.75B$4.07B-19.572,800Positive NewsAXSMAxsome Therapeutics4.7627 of 5 stars$116.31-1.9%$178.00+53.0%+38.9%$5.80B$495.03M-22.94380News CoveragePositive NewsAnalyst ForecastInsider TradeRPRXRoyalty Pharma4.9834 of 5 stars$35.99-0.9%$48.00+33.4%+24.6%$20.99B$2.26B20.8080News CoveragePositive NewsCORTCorcept Therapeutics4.9019 of 5 stars$68.82-2.1%$134.50+95.4%+102.2%$7.25B$716.08M60.90300Positive NewsPRGOPerrigo4.9748 of 5 stars$23.82-2.8%$33.00+38.6%-19.3%$3.28B$4.37B-41.068,379News CoverageAnalyst RevisionSUPNSupernus Pharmaceuticals3.0536 of 5 stars$44.43-1.0%$41.00-7.7%+26.7%$2.49B$665.13M38.63580PCRXPacira BioSciences3.1315 of 5 stars$25.36-1.9%$30.83+21.6%+74.9%$1.14B$705.85M-9.12720Positive NewsNKTRNektar Therapeutics4.0857 of 5 stars$27.14+0.4%$88.33+225.5%+51.5%$516.20M$98.43M-3.09220Positive NewsOMEROmeros3.8755 of 5 stars$4.35-1.1%$18.00+313.8%+1.9%$296.06MN/A-2.06210News CoveragePositive NewsAnalyst ForecastASMBAssembly Biosciences3.2965 of 5 stars$26.62-1.2%$38.67+45.3%+48.4%$204.18M$28.52M-4.77100Short Interest ↑CPIXCumberland Pharmaceuticals0.3397 of 5 stars$3.26-0.9%N/A+173.3%$48.77M$37.87M-14.8280 Related Companies and Tools Related Companies AXSM Alternatives RPRX Alternatives CORT Alternatives PRGO Alternatives SUPN Alternatives PCRX Alternatives NKTR Alternatives OMER Alternatives ASMB Alternatives CPIX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JAZZ) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JAZZ Stock Alerts